深圳市海普瑞药业集团股份有限公司（09989；A股代码：002399）于2026年2月3日披露2026年1月股份变动月报。报告期为2026年1月1日至1月31日。
公司1月份H股股本数量220,094,500股，与上月保持一致；A股股本数量1,247,201,704股，同样未发生变化。截至1月31日，公司注册股本合计为人民币1,467,296,204元，未有新增发行、回购或注销等活动，股本结构维持稳定。
公告称，公司已确认遵守香港联交所《上市规则》及其他相关法律法规。该报告由联席公司秘书钱风奇签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.